Secondary primary malignancies ‘rare’ after CAR T-cell immunotherapy
The incidence of secondary primary malignancy after anti-CD19 chimeric antigen receptor T-cell immunotherapy is very low, according to a study in Nature Medicine. US researchers…
The incidence of secondary primary malignancy after anti-CD19 chimeric antigen receptor T-cell immunotherapy is very low, according to a study in Nature Medicine. US researchers…
Patients at risk of developing arm lymphoedema after breast cancer treatment should be offered prophylactic compression sleeves, according to world-first guidance. Axillary reverse mapping and…
Professors Richard Scolyer and Georgina Long were recently named Australians of the Year. It was for their work in the treatment of melanoma — they…
The names range from Professor Fiona Wood and Dr Brett Sutton to ENT surgeon Professor Kelvin Kong and oncologist Clinical Associate Professor Judith Skinner. A…
Testosterone treatment may increase fracture risk in middle-aged and older men with hypogonadism, according to new research that contradicts conventional wisdom. While exogenous testosterone has…
Targeted alpha therapy is safe and effective for treating metastatic castration-resistant prostate cancer when other anticancer agents have failed, show results from the largest trial…
The TGA is closely watching an overseas investigation of chimeric antigen receptor T-cell therapies after reports of secondary malignancies in treated patients. Last month, the…
This week Dr Matthew Lukies, a Melbourne interventional radiologist, took aim at the Royal Australian and New Zealand College of Radiologists (RANZCR) and the fees…
Isthmocele formation after a previous caesarean section — rather than the C-section itself — lowers the odds of a live birth in women undergoing IVF,…
Total colectomy is the most significant risk factor for anastomotic leak following colon cancer resections, putting patients at four times higher risk of the catastrophic…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.